bcbs not covering glp 1 Blue Cross Blue Shield of Massachusetts will stop popular GLP-1 weight-loss drugs like Ozempic and Wegovy starting January 1, 2026. The decision comes as the costs for these medications have Why we are changing coverage

The American Diabetes Association guidelines support continued use of medications that effectively manage blood glucose and provide additional benefits such as weight loss and cardiovascular protection, with regular reassessment of treatment goals and tolerability

GLP1 medications are a class of drugs that mimic a natural hormone in the body called glucagonlike peptide1, which helps regulate blood sugar and appetite

GLP-1 receptor agonists are being used now off-label to treat osteoarthritis in clinical practice with promising results

There are numerous reviews, which focus on DPP4- and GLP-1-mediated effects, and this topic will not be further discussed here

G.Ortiz-LopezA.et al

If you've been struggling with dark spots, uneven skin tone, or just want that lit-from-within glow, this might just be your next fave discovery